为了解决这一问题，来自瑞典乌普萨拉大学（Uppsala University）和瑞士美敦力公司（Medtronic）等机构的研究人员展开了一项 ... 研究结果显示，在 20 年的时间跨度内，深部脑刺激（deep brain stimulation，DBS）联合最佳药物治疗（best medical therapy，BMT）是最具成本效益 ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology†, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense ...

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no cure for debilitating neurological conditions ...

Now Medtronic has enhanced its Percept DBS neurostimulators with exclusive BrainSense Adaptive technology †, introducing aDBS for people living with Parkinson's. This feature personalizes ...

On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease.